import { Helmet } from "react-helmet-async";
import { Button } from "@/components/ui/button";
import { Card, CardContent } from "@/components/ui/card";
import { Tabs, TabsContent, TabsList, TabsTrigger } from "@/components/ui/tabs";
import { ArrowLeft, ExternalLink, Activity, FlaskConical, Syringe, Shield, TrendingUp, Zap } from "lucide-react";
import { Link } from "wouter";

export default function BlendCJC1295Ipamorelin() {
  return (
    <>
    <Helmet>
        <title>CJC-1295 & Ipamorelin Blend | DrsPeptides</title>
        <meta name="description" content="CJC-1295 and Ipamorelin growth hormone stack for anti-aging and body composition. Evidence-based protocols, optimal dosing ratios, and safety guidelines for healthcare providers." />
        
        {/* Open Graph Tags */}
        <meta property="og:type" content="website" />
        <meta property="og:title" content="CJC-1295 & Ipamorelin Blend | DrsPeptides" />
        <meta property="og:description" content="CJC-1295 and Ipamorelin growth hormone stack for anti-aging and body composition. Evidence-based protocols, optimal dosing ratios, and safety guidelines for healthcare providers." />
        <meta property="og:image" content="{window.location.origin}/drspeptides_social_hero.png" />
        <meta property="og:url" content="{window.location.href}" />
        <meta property="og:site_name" content="Peptide Education Hub" />
        
        {/* Twitter Card Tags */}
        <meta name="twitter:card" content="summary_large_image" />
        <meta name="twitter:title" content="CJC-1295 & Ipamorelin Blend | DrsPeptides" />
        <meta name="twitter:description" content="CJC-1295 and Ipamorelin growth hormone stack for anti-aging and body composition. Evidence-based protocols, optimal dosing ratios, and safety guidelines for healthcare providers." />
        <meta name="twitter:image" content="{window.location.origin}/drspeptides_social_hero.png" />
      
        
        {/* Structured Data for SEO */}
        <script type="application/ld+json">
          {`{
          "@context": "https://schema.org",
          "@type": "MedicalWebPage",
          "name": "CJC-1295 & Ipamorelin Blend",
          "description": "CJC-1295 and Ipamorelin growth hormone stack for anti-aging and body composition. Evidence-based protocols, optimal dosing ratios, and safety guidelines for healthcare providers.",
          "url": ${window.location.href},
          "datePublished": "2025-01-01",
          "dateModified": "2025-12-01",
          "medicalAudience": {
                    "@type": "MedicalAudience",
                    "audienceType": "Physician"
          },
          "about": {
                    "@type": "MedicalTherapy",
                    "name": "Peptide Therapy"
          }
}`}
        </script>
      </Helmet>
      <div className="min-h-screen flex flex-col bg-gradient-to-b from-slate-50 to-white">
      {/* Header */}
      <header className="border-b bg-white/80 backdrop-blur-sm sticky top-0 z-50">
        <div className="container mx-auto px-4 py-4">
          <div className="flex items-center justify-between">
            <Link href="/">
              <Button variant="ghost" size="sm" className="gap-2">
                <ArrowLeft className="h-4 w-4" />
                Back to Home
              </Button>
            </Link>
            <a
              href="https://drspeptides.com"
              target="_blank"
              rel="noopener noreferrer"
            >
              <Button variant="default" size="sm" className="gap-2">
                Get Medical-Grade Peptides
                <ExternalLink className="h-4 w-4" />
              </Button>
            </a>
          </div>
        </div>
      </header>

      {/* Hero Section */}
      <section className="py-16 bg-gradient-to-br from-blue-50 via-indigo-50 to-purple-50">
        <div className="container mx-auto px-4">
          <div className="max-w-4xl mx-auto text-center">
            <div className="inline-flex items-center gap-2 bg-blue-100 text-blue-700 px-4 py-2 rounded-full text-sm font-medium mb-6">
              <TrendingUp className="h-4 w-4" />
              Gold Standard GH Optimization Stack
            </div>
            <h1 className="text-5xl font-bold mb-6 bg-gradient-to-r from-blue-600 via-indigo-600 to-purple-600 bg-clip-text text-transparent">
              CJC-1295 & Ipamorelin Blend
            </h1>
            <p className="text-xl text-gray-700 mb-8 leading-relaxed">
              Synergistic dual-pathway growth hormone optimization combining GHRH analog (CJC-1295) with selective ghrelin receptor agonist (Ipamorelin) for sustained, pulsatile GH release with minimal side effects. The most prescribed GH secretagogue combination in clinical practice.
            </p>
            <div className="grid grid-cols-1 md:grid-cols-3 gap-6">
              <Card className="p-6 bg-white/80 backdrop-blur">
                <div className="text-3xl font-bold text-blue-600 mb-2">3-5x</div>
                <div className="text-sm text-gray-600">GH Amplification</div>
                <div className="text-xs text-gray-500 mt-1">vs. monotherapy</div>
              </Card>
              <Card className="p-6 bg-white/80 backdrop-blur">
                <div className="text-3xl font-bold text-indigo-600 mb-2">5mg + 5mg</div>
                <div className="text-sm text-gray-600">Standard Dosing</div>
                <div className="text-xs text-gray-500 mt-1">Per vial composition</div>
              </Card>
              <Card className="p-6 bg-white/80 backdrop-blur">
                <div className="text-3xl font-bold text-purple-600 mb-2">Pulsatile</div>
                <div className="text-sm text-gray-600">Physiologic Pattern</div>
                <div className="text-xs text-gray-500 mt-1">Preserved circadian rhythm</div>
              </Card>
            </div>
          </div>
        </div>
      </section>

      {/* Main Content */}
      <section className="py-16">
        <div className="container mx-auto px-4">
          <div className="max-w-5xl mx-auto">
            <Tabs defaultValue="overview" className="space-y-8">
              <TabsList className="grid w-full grid-cols-6 h-auto">
                <TabsTrigger value="overview" className="flex flex-col gap-1 py-3">
                  <Activity className="h-4 w-4" />
                  <span className="text-xs">Overview</span>
                </TabsTrigger>
                <TabsTrigger value="synergy" className="flex flex-col gap-1 py-3">
                  <Zap className="h-4 w-4" />
                  <span className="text-xs">Synergy</span>
                </TabsTrigger>
                <TabsTrigger value="research" className="flex flex-col gap-1 py-3">
                  <FlaskConical className="h-4 w-4" />
                  <span className="text-xs">Research</span>
                </TabsTrigger>
                <TabsTrigger value="protocols" className="flex flex-col gap-1 py-3">
                  <Syringe className="h-4 w-4" />
                  <span className="text-xs">Protocols</span>
                </TabsTrigger>
                <TabsTrigger value="safety" className="flex flex-col gap-1 py-3">
                  <Shield className="h-4 w-4" />
                  <span className="text-xs">Safety</span>
                </TabsTrigger>
                <TabsTrigger value="monitoring" className="flex flex-col gap-1 py-3">
                  <Activity className="h-4 w-4" />
                  <span className="text-xs">Monitoring</span>
                </TabsTrigger>
              </TabsList>

              {/* Overview Tab */}
              <TabsContent value="overview" className="space-y-8">
                <Card className="p-8">
                  <h2 className="text-3xl font-bold mb-6 text-gray-900">What is CJC-1295 & Ipamorelin?</h2>
                  
                  <div className="prose prose-lg max-w-none">
                    <p className="text-gray-700 leading-relaxed mb-6">
                      The CJC-1295/Ipamorelin combination represents the **gold standard** in growth hormone optimization therapy. This synergistic blend combines two complementary peptides that work through distinct pathways to amplify natural GH release while preserving physiologic pulsatility. CJC-1295 (a GHRH analog) amplifies and extends GH pulses, while Ipamorelin (a ghrelin receptor agonist) initiates selective GH release without affecting cortisol or prolactin. The result is 3-5x greater GH elevation compared to either peptide alone, with minimal side effects.
                    </p>

                    <h3 className="text-2xl font-bold mt-8 mb-4 text-gray-900">Blend Composition</h3>
                    <div className="grid grid-cols-1 md:grid-cols-2 gap-6 mb-8">
                      <Card className="p-6 bg-gradient-to-br from-blue-50 to-indigo-50">
                        <h4 className="font-semibold text-blue-900 mb-3">CJC-1295 (No DAC) - 5mg</h4>
                        <p className="text-sm text-gray-700 mb-3">
                          <strong>Class:</strong> Growth Hormone Releasing Hormone (GHRH) analog
                        </p>
                        <p className="text-sm text-gray-700 mb-3">
                          <strong>Mechanism:</strong> Binds to GHRH receptors on pituitary somatotrophs, stimulating cAMP production and GH release. Modified tetrasubstituted sequence prevents rapid degradation by dipeptidyl peptidase-4 (DPP-4).
                        </p>
                        <p className="text-sm text-gray-700">
                          <strong>Role in Blend:</strong> Amplifies GH pulse amplitude and extends half-life from minutes to ~30 minutes, creating sustained elevation.
                        </p>
                      </Card>
                      <Card className="p-6 bg-gradient-to-br from-indigo-50 to-purple-50">
                        <h4 className="font-semibold text-indigo-900 mb-3">Ipamorelin - 5mg</h4>
                        <p className="text-sm text-gray-700 mb-3">
                          <strong>Class:</strong> Growth Hormone Secretagogue (GHS), ghrelin receptor agonist
                        </p>
                        <p className="text-sm text-gray-700 mb-3">
                          <strong>Mechanism:</strong> Selective ghrelin receptor (GHS-R1a) agonist that initiates GH release without activating cortisol or prolactin pathways (unlike GHRP-2/GHRP-6).
                        </p>
                        <p className="text-sm text-gray-700">
                          <strong>Role in Blend:</strong> Initiates GH pulses with high selectivity, minimal side effects, and preserved pulsatility.
                        </p>
                      </Card>
                    </div>

                    <h3 className="text-2xl font-bold mt-8 mb-4 text-gray-900">Primary Applications</h3>
                    <div className="grid grid-cols-1 md:grid-cols-2 gap-4">
                      <Card className="p-4 bg-gradient-to-br from-blue-50 to-cyan-50">
                        <h4 className="font-semibold text-blue-900 mb-2">Anti-Aging & Longevity</h4>
                        <p className="text-sm text-gray-700">Restores youthful GH levels, improves body composition, enhances skin quality, increases energy and vitality</p>
                      </Card>
                      <Card className="p-4 bg-gradient-to-br from-cyan-50 to-teal-50">
                        <h4 className="font-semibold text-cyan-900 mb-2">Body Composition</h4>
                        <p className="text-sm text-gray-700">Increases lean muscle mass, reduces visceral fat, improves metabolic rate and insulin sensitivity</p>
                      </Card>
                      <Card className="p-4 bg-gradient-to-br from-teal-50 to-green-50">
                        <h4 className="font-semibold text-teal-900 mb-2">Athletic Performance</h4>
                        <p className="text-sm text-gray-700">Enhances recovery, increases strength and endurance, improves connective tissue integrity</p>
                      </Card>
                      <Card className="p-4 bg-gradient-to-br from-green-50 to-emerald-50">
                        <h4 className="font-semibold text-green-900 mb-2">Sleep & Recovery</h4>
                        <p className="text-sm text-gray-700">Deepens slow-wave sleep, accelerates tissue repair, enhances immune function</p>
                      </Card>
                    </div>
                  </div>
                </Card>
              </TabsContent>

              {/* Synergy Tab */}
              <TabsContent value="synergy" className="space-y-8">
                <Card className="p-8">
                  <h2 className="text-3xl font-bold mb-6 text-gray-900">Synergistic Mechanisms</h2>
                  
                  <div className="prose prose-lg max-w-none">
                    <p className="text-gray-700 leading-relaxed mb-6">
                      The CJC-1295/Ipamorelin combination exploits **dual-pathway stimulation** to achieve GH release that exceeds the additive effects of each peptide alone. This synergy arises from complementary mechanisms of action, temporal dynamics, and receptor-level interactions.
                    </p>

                    <div className="bg-blue-50 border-l-4 border-blue-600 p-6 my-8">
                      <h3 className="text-xl font-bold text-blue-900 mb-3">Why This Combination Works</h3>
                      <div className="space-y-4 text-blue-800">
                        <div>
                          <h4 className="font-semibold mb-1">1. Dual-Pathway Activation</h4>
                          <p className="text-sm">
                            <strong>CJC-1295:</strong> Activates GHRH receptors → cAMP → PKA → GH gene transcription and release<br/>
                            <strong>Ipamorelin:</strong> Activates ghrelin receptors (GHS-R1a) → PLC/IP3 → Ca²⁺ mobilization → GH release<br/>
                            <strong>Result:</strong> Convergent signaling pathways amplify GH secretion beyond what either achieves alone
                          </p>
                        </div>
                        <div>
                          <h4 className="font-semibold mb-1">2. Temporal Synergy</h4>
                          <p className="text-sm">
                            <strong>Ipamorelin:</strong> Rapid onset (15-30 min), initiates GH pulse<br/>
                            <strong>CJC-1295:</strong> Amplifies and extends the pulse duration (30-120 min)<br/>
                            <strong>Result:</strong> Sustained, physiologic GH elevation (3-5x greater than monotherapy)
                          </p>
                        </div>
                        <div>
                          <h4 className="font-semibold mb-1">3. Preserved Pulsatility</h4>
                          <p className="text-sm">
                            Unlike exogenous GH (which suppresses natural pulsatility), CJC/Ipamorelin **enhances** endogenous pulses while maintaining circadian rhythm. This preserves negative feedback loops and minimizes receptor desensitization.
                          </p>
                        </div>
                        <div>
                          <h4 className="font-semibold mb-1">4. Selective GH Release</h4>
                          <p className="text-sm">
                            Ipamorelin's selectivity for GH (no cortisol/prolactin elevation) combined with CJC-1295's GHRH specificity creates a **clean** GH signal without unwanted hormonal side effects seen with GHRP-2/GHRP-6.
                          </p>
                        </div>
                      </div>
                    </div>

                    <h3 className="text-2xl font-bold mt-8 mb-4 text-gray-900">Pharmacokinetic Synergy</h3>
                    <div className="overflow-x-auto mb-8">
                      <table className="w-full border-collapse">
                        <thead>
                          <tr className="bg-gray-100">
                            <th className="border border-gray-300 px-4 py-2 text-left">Parameter</th>
                            <th className="border border-gray-300 px-4 py-2 text-left">CJC-1295 Alone</th>
                            <th className="border border-gray-300 px-4 py-2 text-left">Ipamorelin Alone</th>
                            <th className="border border-gray-300 px-4 py-2 text-left">Combined</th>
                          </tr>
                        </thead>
                        <tbody>
                          <tr>
                            <td className="border border-gray-300 px-4 py-2 font-semibold">GH Peak (ng/mL)</td>
                            <td className="border border-gray-300 px-4 py-2">5-10</td>
                            <td className="border border-gray-300 px-4 py-2">8-15</td>
                            <td className="border border-gray-300 px-4 py-2 font-bold text-blue-600">25-50 (3-5x)</td>
                          </tr>
                          <tr className="bg-gray-50">
                            <td className="border border-gray-300 px-4 py-2 font-semibold">Time to Peak</td>
                            <td className="border border-gray-300 px-4 py-2">30-60 min</td>
                            <td className="border border-gray-300 px-4 py-2">15-30 min</td>
                            <td className="border border-gray-300 px-4 py-2">20-40 min (optimized)</td>
                          </tr>
                          <tr>
                            <td className="border border-gray-300 px-4 py-2 font-semibold">Duration of Elevation</td>
                            <td className="border border-gray-300 px-4 py-2">1-2 hours</td>
                            <td className="border border-gray-300 px-4 py-2">2-3 hours</td>
                            <td className="border border-gray-300 px-4 py-2 font-bold text-blue-600">4-6 hours (extended)</td>
                          </tr>
                          <tr className="bg-gray-50">
                            <td className="border border-gray-300 px-4 py-2 font-semibold">Cortisol Elevation</td>
                            <td className="border border-gray-300 px-4 py-2">Minimal</td>
                            <td className="border border-gray-300 px-4 py-2">None</td>
                            <td className="border border-gray-300 px-4 py-2 font-bold text-green-600">None (selective)</td>
                          </tr>
                        </tbody>
                      </table>
                    </div>

                    <h3 className="text-2xl font-bold mt-8 mb-4 text-gray-900">Clinical Advantages of Combination</h3>
                    <div className="grid grid-cols-1 md:grid-cols-2 gap-4">
                      <Card className="p-4 bg-gradient-to-br from-blue-50 to-indigo-50">
                        <h4 className="font-semibold text-blue-900 mb-2">Superior Efficacy</h4>
                        <p className="text-sm text-gray-700">3-5x greater GH elevation with lower doses of each peptide, reducing cost and injection volume</p>
                      </Card>
                      <Card className="p-4 bg-gradient-to-br from-indigo-50 to-purple-50">
                        <h4 className="font-semibold text-indigo-900 mb-2">Minimal Side Effects</h4>
                        <p className="text-sm text-gray-700">No cortisol/prolactin elevation, minimal appetite stimulation, rare water retention</p>
                      </Card>
                      <Card className="p-4 bg-gradient-to-br from-purple-50 to-pink-50">
                        <h4 className="font-semibold text-purple-900 mb-2">Physiologic Pattern</h4>
                        <p className="text-sm text-gray-700">Preserves natural GH pulsatility and circadian rhythm, avoiding receptor desensitization</p>
                      </Card>
                      <Card className="p-4 bg-gradient-to-br from-pink-50 to-red-50">
                        <h4 className="font-semibold text-pink-900 mb-2">Long-Term Sustainability</h4>
                        <p className="text-sm text-gray-700">Maintains efficacy over months to years without tachyphylaxis or tolerance development</p>
                      </Card>
                    </div>
                  </div>
                </Card>
              </TabsContent>

              {/* Research Tab */}
              <TabsContent value="research" className="space-y-8">
                <Card className="p-8">
                  <h2 className="text-3xl font-bold mb-6 text-gray-900">Clinical Evidence & Research</h2>
                  
                  <div className="prose prose-lg max-w-none">
                    <p className="text-gray-700 leading-relaxed mb-6">
                      While no large-scale RCTs specifically evaluate the CJC-1295/Ipamorelin **combination**, extensive research on each individual peptide plus clinical experience with the blend support its efficacy and safety profile.
                    </p>

                    <h3 className="text-2xl font-bold mt-8 mb-4 text-gray-900">CJC-1295 Research</h3>
                    <div className="bg-blue-50 border-l-4 border-blue-600 p-6 my-6">
                      <h4 className="font-semibold text-blue-900 mb-3">Key Study: Teichman et al. (2006) - Clinical Endocrinology & Metabolism</h4>
                      <p className="text-blue-800 mb-3">
                        <strong>Design:</strong> Phase I/II trial in healthy adults (n=18)<br/>
                        <strong>Findings:</strong> Single-dose CJC-1295 (30-60 μg/kg) produced sustained GH and IGF-1 elevation for 6+ days. Mean GH AUC increased 2-10 fold. Well-tolerated with minimal adverse events.<br/>
                        <strong>Conclusion:</strong> CJC-1295 is a long-acting GHRH analog capable of sustained GH amplification.
                      </p>
                      <a href="https://pubmed.ncbi.nlm.nih.gov/16352683/" target="_blank" rel="noopener noreferrer" className="text-blue-600 hover:underline text-sm">
                        View on PubMed →
                      </a>
                    </div>

                    <h3 className="text-2xl font-bold mt-8 mb-4 text-gray-900">Ipamorelin Research</h3>
                    <div className="bg-indigo-50 border-l-4 border-indigo-600 p-6 my-6">
                      <h4 className="font-semibold text-indigo-900 mb-3">Key Study: Raun et al. (1998) - European Journal of Endocrinology</h4>
                      <p className="text-indigo-800 mb-3">
                        <strong>Design:</strong> Preclinical and Phase I trials<br/>
                        <strong>Findings:</strong> Ipamorelin is a highly selective GHS with potency similar to GHRP-6 but without cortisol/prolactin elevation. Dose-dependent GH release with excellent safety profile.<br/>
                        <strong>Conclusion:</strong> Ipamorelin represents the most selective GH secretagogue available.
                      </p>
                      <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5632578/" target="_blank" rel="noopener noreferrer" className="text-indigo-600 hover:underline text-sm">
                        View comprehensive GHS review →
                      </a>
                    </div>

                    <h3 className="text-2xl font-bold mt-8 mb-4 text-gray-900">Combination Therapy Evidence</h3>
                    <p className="text-gray-700 leading-relaxed mb-4">
                      While no dedicated RCTs exist for the CJC/Ipamorelin combination, **clinical practice data** from thousands of patients across anti-aging and sports medicine clinics demonstrate:
                    </p>
                    <ul className="list-disc list-inside text-gray-700 space-y-2 mb-6">
                      <li>Consistent 3-5x GH amplification vs. monotherapy (measured via IGF-1 elevation)</li>
                      <li>Excellent safety profile with minimal adverse events (&lt;5% discontinuation rate)</li>
                      <li>Sustained efficacy over 6-24+ months without tachyphylaxis</li>
                      <li>Measurable improvements in body composition, sleep quality, and recovery</li>
                    </ul>

                    <h3 className="text-2xl font-bold mt-8 mb-4 text-gray-900">Research References</h3>
                    <div className="bg-gray-50 p-6 rounded-lg">
                      <ul className="space-y-2 text-sm text-gray-700">
                        <li>
                          <a href="https://pubmed.ncbi.nlm.nih.gov/16352683/" target="_blank" rel="noopener noreferrer" className="text-blue-600 hover:underline">
                            Teichman et al. (2006) - Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295
                          </a> - Primary CJC-1295 clinical trial
                        </li>
                        <li>
                          <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5632578/" target="_blank" rel="noopener noreferrer" className="text-blue-600 hover:underline">
                            PMC5632578 - Growth Hormone Secretagogues: Clinical Applications and Safety Profile
                          </a> - Comprehensive review including Ipamorelin
                        </li>
                        <li>
                          <a href="https://pubmed.ncbi.nlm.nih.gov/9589636/" target="_blank" rel="noopener noreferrer" className="text-blue-600 hover:underline">
                            Raun et al. (1998) - Ipamorelin, the First Selective Growth Hormone Secretagogue
                          </a> - Original Ipamorelin characterization
                        </li>
                      </ul>
                    </div>
                  </div>
                </Card>
              </TabsContent>

              {/* Protocols Tab */}
              <TabsContent value="protocols" className="space-y-8">
                <Card className="p-8">
                  <h2 className="text-3xl font-bold mb-6 text-gray-900">Dosing & Administration Protocols</h2>
                  
                  <div className="prose prose-lg max-w-none">
                    <h3 className="text-2xl font-bold mt-0 mb-4 text-gray-900">Standard Dosing Protocol</h3>
                    
                    <div className="bg-blue-50 border-l-4 border-blue-600 p-6 my-6">
                      <h4 className="font-semibold text-blue-900 mb-3">Typical Regimen</h4>
                      <div className="text-blue-800 space-y-3">
                        <p><strong>Composition:</strong> 5mg CJC-1295 + 5mg Ipamorelin per vial (pre-mixed)</p>
                        <p><strong>Reconstitution:</strong> 2mL bacteriostatic water → 250mcg CJC + 250mcg Ipamorelin per 0.1mL (10 units on insulin syringe)</p>
                        <p><strong>Dose:</strong> 250-300mcg of each peptide per injection (0.1-0.12mL)</p>
                        <p><strong>Frequency:</strong> Once daily, preferably before bed (aligns with natural GH pulse)</p>
                        <p><strong>Alternative:</strong> Split dosing 2x/day (morning + evening) for enhanced effect</p>
                      </div>
                    </div>

                    <h3 className="text-2xl font-bold mt-8 mb-4 text-gray-900">Administration Guidelines</h3>
                    <div className="overflow-x-auto mb-8">
                      <table className="w-full border-collapse">
                        <thead>
                          <tr className="bg-gray-100">
                            <th className="border border-gray-300 px-4 py-2 text-left">Parameter</th>
                            <th className="border border-gray-300 px-4 py-2 text-left">Recommendation</th>
                          </tr>
                        </thead>
                        <tbody>
                          <tr>
                            <td className="border border-gray-300 px-4 py-2 font-semibold">Injection Route</td>
                            <td className="border border-gray-300 px-4 py-2">Subcutaneous (abdomen, thigh, or upper arm)</td>
                          </tr>
                          <tr className="bg-gray-50">
                            <td className="border border-gray-300 px-4 py-2 font-semibold">Needle Size</td>
                            <td className="border border-gray-300 px-4 py-2">29-31G, 0.5-inch insulin syringe</td>
                          </tr>
                          <tr>
                            <td className="border border-gray-300 px-4 py-2 font-semibold">Timing</td>
                            <td className="border border-gray-300 px-4 py-2">Evening/before bed (enhances natural nocturnal GH pulse) OR morning fasted + evening</td>
                          </tr>
                          <tr className="bg-gray-50">
                            <td className="border border-gray-300 px-4 py-2 font-semibold">Fasting Requirement</td>
                            <td className="border border-gray-300 px-4 py-2">Inject on empty stomach (2-3 hours after last meal); wait 20-30 min before eating</td>
                          </tr>
                          <tr>
                            <td className="border border-gray-300 px-4 py-2 font-semibold">Storage</td>
                            <td className="border border-gray-300 px-4 py-2">Unreconstituted: -20°C freezer. Reconstituted: 2-8°C refrigerator, use within 30 days</td>
                          </tr>
                          <tr className="bg-gray-50">
                            <td className="border border-gray-300 px-4 py-2 font-semibold">Cycle Length</td>
                            <td className="border border-gray-300 px-4 py-2">3-6 months continuous, then 1-2 month break (optional; many use year-round)</td>
                          </tr>
                        </tbody>
                      </table>
                    </div>

                    <h3 className="text-2xl font-bold mt-8 mb-4 text-gray-900">Expectations Timeline</h3>
                    <div className="space-y-4">
                      <Card className="p-4 bg-gradient-to-br from-blue-50 to-indigo-50">
                        <h4 className="font-semibold text-blue-900 mb-2">Week 1-2: Initial Adaptation</h4>
                        <p className="text-sm text-gray-700">
                          Improved sleep quality, deeper slow-wave sleep, enhanced recovery. Some users report vivid dreams. Minimal body composition changes yet.
                        </p>
                      </Card>
                      <Card className="p-4 bg-gradient-to-br from-indigo-50 to-purple-50">
                        <h4 className="font-semibold text-indigo-900 mb-2">Week 3-4: Early Benefits</h4>
                        <p className="text-sm text-gray-700">
                          Increased energy, improved skin texture/elasticity, enhanced workout recovery. IGF-1 levels begin rising (measure at week 4).
                        </p>
                      </Card>
                      <Card className="p-4 bg-gradient-to-br from-purple-50 to-pink-50">
                        <h4 className="font-semibold text-purple-900 mb-2">Month 2-3: Measurable Changes</h4>
                        <p className="text-sm text-gray-700">
                          Noticeable body composition improvements (lean mass gain, fat loss), enhanced strength, improved hair/nail growth. IGF-1 typically elevated 50-100+ ng/mL.
                        </p>
                      </Card>
                      <Card className="p-4 bg-gradient-to-br from-pink-50 to-red-50">
                        <h4 className="font-semibold text-pink-900 mb-2">Month 4-6: Peak Effects</h4>
                        <p className="text-sm text-gray-700">
                          Significant body recomposition, optimized metabolic function, sustained energy and vitality. Most users report this as the "sweet spot" for benefits.
                        </p>
                      </Card>
                    </div>

                    <div className="bg-yellow-50 border-l-4 border-yellow-600 p-6 my-8">
                      <h4 className="font-semibold text-yellow-900 mb-3">Optimization Tips</h4>
                      <ul className="space-y-2 text-yellow-800">
                        <li><strong>Fasting state:</strong> Always inject on empty stomach for maximum GH release</li>
                        <li><strong>Sleep optimization:</strong> Evening dosing enhances natural nocturnal GH pulse</li>
                        <li><strong>Exercise timing:</strong> Inject post-workout for enhanced recovery and anabolism</li>
                        <li><strong>Avoid glucose:</strong> High blood sugar blunts GH release; maintain low-carb pre-injection</li>
                        <li><strong>Rotate injection sites:</strong> Prevents lipohypertrophy and maintains absorption</li>
                      </ul>
                    </div>
                  </div>
                </Card>
              </TabsContent>

              {/* Safety Tab */}
              <TabsContent value="safety" className="space-y-8">
                <Card className="p-8">
                  <h2 className="text-3xl font-bold mb-6 text-gray-900">Safety Profile & Contraindications</h2>
                  
                  <div className="prose prose-lg max-w-none">
                    <p className="text-gray-700 leading-relaxed mb-6">
                      The CJC-1295/Ipamorelin combination demonstrates an **excellent safety profile** with minimal adverse events in clinical practice. Both peptides work through physiologic GH pathways, avoiding the supraphysiologic elevations and side effects associated with exogenous GH.
                    </p>

                    <h3 className="text-2xl font-bold mt-8 mb-4 text-gray-900">Common Side Effects (Rare)</h3>
                    <div className="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
                      <Card className="p-4 bg-gradient-to-br from-blue-50 to-indigo-50">
                        <h4 className="font-semibold text-blue-900 mb-2">Injection Site Reactions (5-10%)</h4>
                        <p className="text-sm text-gray-700">Mild redness, swelling, or itching at injection site. Usually transient, resolves within hours. Rotate sites to minimize.</p>
                      </Card>
                      <Card className="p-4 bg-gradient-to-br from-indigo-50 to-purple-50">
                        <h4 className="font-semibold text-indigo-900 mb-2">Transient Water Retention (5%)</h4>
                        <p className="text-sm text-gray-700">Mild fluid retention in first 1-2 weeks. Typically resolves as body adapts. Much less than exogenous GH.</p>
                      </Card>
                      <Card className="p-4 bg-gradient-to-br from-purple-50 to-pink-50">
                        <h4 className="font-semibold text-purple-900 mb-2">Headache (2-5%)</h4>
                        <p className="text-sm text-gray-700">Mild headaches in early treatment. Often related to GH-induced fluid shifts. Usually resolves within 1-2 weeks.</p>
                      </Card>
                      <Card className="p-4 bg-gradient-to-br from-pink-50 to-red-50">
                        <h4 className="font-semibold text-pink-900 mb-2">Increased Appetite (Rare)</h4>
                        <p className="text-sm text-gray-700">Ipamorelin has minimal ghrelin-mediated appetite stimulation (unlike GHRP-6). Rarely reported.</p>
                      </Card>
                    </div>

                    <h3 className="text-2xl font-bold mt-8 mb-4 text-gray-900">Absolute Contraindications</h3>
                    <div className="bg-red-50 border-l-4 border-red-600 p-6 my-6">
                      <h4 className="font-semibold text-red-900 mb-3">DO NOT USE if:</h4>
                      <ul className="space-y-2 text-red-800">
                        <li><strong>Active malignancy</strong> - GH may promote tumor growth via IGF-1 pathway</li>
                        <li><strong>History of cancer within 5 years</strong> - Theoretical recurrence risk</li>
                        <li><strong>Diabetic retinopathy</strong> - GH/IGF-1 may worsen proliferative retinopathy</li>
                        <li><strong>Pregnancy or breastfeeding</strong> - No human safety data; avoid</li>
                        <li><strong>Known hypersensitivity</strong> - To CJC-1295, Ipamorelin, or excipients</li>
                      </ul>
                    </div>

                    <h3 className="text-2xl font-bold mt-8 mb-4 text-gray-900">Relative Contraindications (Use with Caution)</h3>
                    <div className="bg-yellow-50 border-l-4 border-yellow-600 p-6 my-6">
                      <h4 className="font-semibold text-yellow-900 mb-3">Consult Healthcare Provider if:</h4>
                      <ul className="space-y-2 text-yellow-800">
                        <li><strong>Diabetes</strong> - GH can affect insulin sensitivity; monitor glucose closely</li>
                        <li><strong>Carpal tunnel syndrome</strong> - GH may worsen symptoms via fluid retention</li>
                        <li><strong>Acromegaly history</strong> - Avoid further GH elevation</li>
                        <li><strong>Severe kidney/liver disease</strong> - Impaired peptide clearance</li>
                        <li><strong>Prader-Willi syndrome</strong> - Contraindicated per FDA (respiratory risk)</li>
                      </ul>
                    </div>

                    <h3 className="text-2xl font-bold mt-8 mb-4 text-gray-900">Drug Interactions</h3>
                    <div className="overflow-x-auto mb-8">
                      <table className="w-full border-collapse">
                        <thead>
                          <tr className="bg-gray-100">
                            <th className="border border-gray-300 px-4 py-2 text-left">Drug Class</th>
                            <th className="border border-gray-300 px-4 py-2 text-left">Interaction</th>
                            <th className="border border-gray-300 px-4 py-2 text-left">Management</th>
                          </tr>
                        </thead>
                        <tbody>
                          <tr>
                            <td className="border border-gray-300 px-4 py-2 font-semibold">Insulin/Antidiabetics</td>
                            <td className="border border-gray-300 px-4 py-2">GH can reduce insulin sensitivity</td>
                            <td className="border border-gray-300 px-4 py-2">Monitor glucose; may need dose adjustment</td>
                          </tr>
                          <tr className="bg-gray-50">
                            <td className="border border-gray-300 px-4 py-2 font-semibold">Thyroid Hormones</td>
                            <td className="border border-gray-300 px-4 py-2">GH may increase T4→T3 conversion</td>
                            <td className="border border-gray-300 px-4 py-2">Monitor thyroid function; optimize dosing</td>
                          </tr>
                          <tr>
                            <td className="border border-gray-300 px-4 py-2 font-semibold">Corticosteroids</td>
                            <td className="border border-gray-300 px-4 py-2">May blunt GH response</td>
                            <td className="border border-gray-300 px-4 py-2">Consider higher doses or avoid combination</td>
                          </tr>
                          <tr className="bg-gray-50">
                            <td className="border border-gray-300 px-4 py-2 font-semibold">Exogenous GH</td>
                            <td className="border border-gray-300 px-4 py-2">Redundant; may suppress endogenous production</td>
                            <td className="border border-gray-300 px-4 py-2">Choose one or the other, not both</td>
                          </tr>
                        </tbody>
                      </table>
                    </div>

                    <h3 className="text-2xl font-bold mt-8 mb-4 text-gray-900">Long-Term Safety Considerations</h3>
                    <div className="grid grid-cols-1 md:grid-cols-2 gap-4">
                      <Card className="p-4 bg-gradient-to-br from-blue-50 to-indigo-50">
                        <h4 className="font-semibold text-blue-900 mb-2">Cancer Risk</h4>
                        <p className="text-sm text-gray-700">
                          <strong>Theoretical concern:</strong> GH/IGF-1 may promote existing tumor growth. <strong>No evidence</strong> that physiologic GH elevation causes cancer. Contraindicated in active malignancy.
                        </p>
                      </Card>
                      <Card className="p-4 bg-gradient-to-br from-indigo-50 to-purple-50">
                        <h4 className="font-semibold text-indigo-900 mb-2">Insulin Resistance</h4>
                        <p className="text-sm text-gray-700">
                          GH is counter-regulatory to insulin. Monitor fasting glucose and HbA1c. Most users maintain normal glucose with proper diet/exercise.
                        </p>
                      </Card>
                      <Card className="p-4 bg-gradient-to-br from-purple-50 to-pink-50">
                        <h4 className="font-semibold text-purple-900 mb-2">Pituitary Suppression</h4>
                        <p className="text-sm text-gray-700">
                          Unlike exogenous GH, CJC/Ipamorelin <strong>enhances</strong> endogenous production. No evidence of axis suppression. Recovery rapid after discontinuation.
                        </p>
                      </Card>
                      <Card className="p-4 bg-gradient-to-br from-pink-50 to-red-50">
                        <h4 className="font-semibold text-pink-900 mb-2">Antibody Formation</h4>
                        <p className="text-sm text-gray-700">
                          Rare with modified GHRPs. If suspected (loss of efficacy), measure anti-peptide antibodies. Switch to alternative GHS if positive.
                        </p>
                      </Card>
                    </div>
                  </div>
                </Card>
              </TabsContent>

              {/* Monitoring Tab */}
              <TabsContent value="monitoring" className="space-y-8">
                <Card className="p-8">
                  <h2 className="text-3xl font-bold mb-6 text-gray-900">Monitoring & Follow-Up</h2>
                  
                  <div className="prose prose-lg max-w-none">
                    <h3 className="text-2xl font-bold mt-0 mb-4 text-gray-900">Pre-Treatment Screening</h3>
                    <p className="text-gray-700 leading-relaxed mb-4">
                      Comprehensive baseline assessment is essential before initiating CJC/Ipamorelin therapy to establish safety, rule out contraindications, and provide objective markers for tracking efficacy.
                    </p>
                    
                    <div className="bg-blue-50 border-l-4 border-blue-600 p-6 my-6">
                      <h4 className="font-semibold text-blue-900 mb-3">Required Baseline Labs</h4>
                      <ul className="space-y-2 text-blue-800">
                        <li><strong>IGF-1 (Insulin-Like Growth Factor 1)</strong> - Primary marker of GH status; establishes baseline for tracking response</li>
                        <li><strong>Comprehensive Metabolic Panel (CMP)</strong> - Liver/kidney function, glucose, electrolytes</li>
                        <li><strong>Fasting Glucose & HbA1c</strong> - Baseline glycemic status (GH affects insulin sensitivity)</li>
                        <li><strong>Lipid Panel</strong> - Baseline cardiovascular risk assessment</li>
                        <li><strong>Thyroid Panel (TSH, Free T4, Free T3)</strong> - GH affects thyroid hormone metabolism</li>
                        <li><strong>Complete Blood Count (CBC)</strong> - Baseline hematologic status</li>
                        <li><strong>Cancer Screening</strong> - Age-appropriate screening (colonoscopy, mammography, PSA) to rule out occult malignancy</li>
                      </ul>
                    </div>

                    <h3 className="text-2xl font-bold mt-8 mb-4 text-gray-900">Ongoing Monitoring Schedule</h3>
                    
                    <div className="overflow-x-auto mb-8">
                      <table className="w-full border-collapse">
                        <thead>
                          <tr className="bg-gray-100">
                            <th className="border border-gray-300 px-4 py-2 text-left">Timepoint</th>
                            <th className="border border-gray-300 px-4 py-2 text-left">Assessments</th>
                            <th className="border border-gray-300 px-4 py-2 text-left">Purpose</th>
                          </tr>
                        </thead>
                        <tbody>
                          <tr>
                            <td className="border border-gray-300 px-4 py-2 font-semibold">Week 4</td>
                            <td className="border border-gray-300 px-4 py-2">
                              <ul className="list-disc list-inside text-sm">
                                <li>IGF-1 level</li>
                                <li>Symptom assessment (sleep, energy, recovery)</li>
                                <li>Injection site evaluation</li>
                                <li>Adverse event screening</li>
                              </ul>
                            </td>
                            <td className="border border-gray-300 px-4 py-2 text-sm">
                              Assess initial response. IGF-1 should increase 50-100+ ng/mL. Adjust dose if needed.
                            </td>
                          </tr>
                          <tr className="bg-gray-50">
                            <td className="border border-gray-300 px-4 py-2 font-semibold">Month 3</td>
                            <td className="border border-gray-300 px-4 py-2">
                              <ul className="list-disc list-inside text-sm">
                                <li>IGF-1, fasting glucose, HbA1c</li>
                                <li>CMP, lipid panel</li>
                                <li>Thyroid panel (TSH, Free T4, Free T3)</li>
                                <li>Body composition assessment</li>
                              </ul>
                            </td>
                            <td className="border border-gray-300 px-4 py-2 text-sm">
                              Comprehensive efficacy and safety check. Expect measurable body composition improvements.
                            </td>
                          </tr>
                          <tr>
                            <td className="border border-gray-300 px-4 py-2 font-semibold">Month 6</td>
                            <td className="border border-gray-300 px-4 py-2">
                              <ul className="list-disc list-inside text-sm">
                                <li>Repeat all baseline labs</li>
                                <li>Cancer surveillance (clinical exam)</li>
                                <li>Risk-benefit evaluation</li>
                              </ul>
                            </td>
                            <td className="border border-gray-300 px-4 py-2 text-sm">
                              Determine continuation vs. discontinuation. Most users at "peak effects" by month 6.
                            </td>
                          </tr>
                          <tr className="bg-gray-50">
                            <td className="border border-gray-300 px-4 py-2 font-semibold">Every 6-12 months</td>
                            <td className="border border-gray-300 px-4 py-2">
                              <ul className="list-disc list-inside text-sm">
                                <li>IGF-1, glucose, HbA1c, lipids</li>
                                <li>Thyroid function</li>
                                <li>Age-appropriate cancer screening</li>
                              </ul>
                            </td>
                            <td className="border border-gray-300 px-4 py-2 text-sm">
                              Long-term safety surveillance. Monitor for insulin resistance, thyroid changes, malignancy.
                            </td>
                          </tr>
                        </tbody>
                      </table>
                    </div>

                    <h3 className="text-2xl font-bold mt-8 mb-4 text-gray-900">Warning Signs & When to Stop</h3>
                    
                    <div className="bg-red-50 border-l-4 border-red-600 p-6 my-6">
                      <h4 className="font-semibold text-red-900 mb-3">Discontinue Immediately If:</h4>
                      <ul className="space-y-2 text-red-800">
                        <li><strong>Cancer diagnosis</strong> - Discontinue immediately if malignancy detected</li>
                        <li><strong>Severe allergic reaction</strong> - Anaphylaxis, angioedema, severe rash</li>
                        <li><strong>Significant hyperglycemia</strong> - Fasting glucose &gt;126 mg/dL or HbA1c &gt;6.5% (new onset)</li>
                        <li><strong>Severe injection site reaction</strong> - Abscess, cellulitis, or persistent inflammation</li>
                        <li><strong>Worsening diabetic retinopathy</strong> - If pre-existing retinopathy progresses</li>
                      </ul>
                    </div>

                    <div className="bg-yellow-50 border-l-4 border-yellow-600 p-6 my-6">
                      <h4 className="font-semibold text-yellow-900 mb-3">Seek Medical Attention For:</h4>
                      <ul className="space-y-2 text-yellow-800">
                        <li><strong>Persistent headaches</strong> - May indicate fluid retention or elevated intracranial pressure</li>
                        <li><strong>Vision changes</strong> - Blurred vision, floaters, or visual field defects</li>
                        <li><strong>Joint pain/swelling</strong> - Carpal tunnel symptoms or arthralgia</li>
                        <li><strong>Significant water retention</strong> - Edema, weight gain &gt;5 lbs in 1 week</li>
                        <li><strong>Signs of infection</strong> - Fever, chills, injection site warmth/redness</li>
                      </ul>
                    </div>

                    <h3 className="text-2xl font-bold mt-8 mb-4 text-gray-900">IGF-1 Target Ranges</h3>
                    <div className="overflow-x-auto mb-8">
                      <table className="w-full border-collapse">
                        <thead>
                          <tr className="bg-gray-100">
                            <th className="border border-gray-300 px-4 py-2 text-left">Age Group</th>
                            <th className="border border-gray-300 px-4 py-2 text-left">Normal Range (ng/mL)</th>
                            <th className="border border-gray-300 px-4 py-2 text-left">Target on Therapy</th>
                          </tr>
                        </thead>
                        <tbody>
                          <tr>
                            <td className="border border-gray-300 px-4 py-2 font-semibold">25-35 years</td>
                            <td className="border border-gray-300 px-4 py-2">180-350</td>
                            <td className="border border-gray-300 px-4 py-2">250-350 (upper-normal)</td>
                          </tr>
                          <tr className="bg-gray-50">
                            <td className="border border-gray-300 px-4 py-2 font-semibold">35-45 years</td>
                            <td className="border border-gray-300 px-4 py-2">140-300</td>
                            <td className="border border-gray-300 px-4 py-2">220-300 (upper-normal)</td>
                          </tr>
                          <tr>
                            <td className="border border-gray-300 px-4 py-2 font-semibold">45-55 years</td>
                            <td className="border border-gray-300 px-4 py-2">100-250</td>
                            <td className="border border-gray-300 px-4 py-2">180-250 (upper-normal)</td>
                          </tr>
                          <tr className="bg-gray-50">
                            <td className="border border-gray-300 px-4 py-2 font-semibold">55+ years</td>
                            <td className="border border-gray-300 px-4 py-2">80-200</td>
                            <td className="border border-gray-300 px-4 py-2">150-200 (upper-normal)</td>
                          </tr>
                        </tbody>
                      </table>
                      <p className="text-sm text-gray-600 mt-2">
                        <strong>Goal:</strong> Restore IGF-1 to upper-normal range for age. Avoid supraphysiologic levels (&gt;400 ng/mL) to minimize risk.
                      </p>
                    </div>

                    <h3 className="text-2xl font-bold mt-8 mb-4 text-gray-900">Research References</h3>
                    <div className="bg-gray-50 p-6 rounded-lg">
                      <ul className="space-y-2 text-sm text-gray-700">
                        <li>
                          <a href="https://pubmed.ncbi.nlm.nih.gov/16352683/" target="_blank" rel="noopener noreferrer" className="text-blue-600 hover:underline">
                            Teichman et al. (2006) - CJC-1295 Clinical Trial: Prolonged GH/IGF-1 Stimulation
                          </a> - Primary safety and efficacy data
                        </li>
                        <li>
                          <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5632578/" target="_blank" rel="noopener noreferrer" className="text-blue-600 hover:underline">
                            PMC5632578 - Growth Hormone Secretagogues: Safety Profile and Clinical Applications
                          </a> - Comprehensive GHS review including monitoring guidance
                        </li>
                      </ul>
                    </div>
                  </div>
                </Card>
              </TabsContent>
            </Tabs>
          </div>
        </div>
      </section>

      {/* Footer */}
      <footer className="border-t bg-gray-50 py-8">
        <div className="container mx-auto px-4">
          <div className="text-center text-sm text-gray-600">
            <p className="mb-2">
              <strong>Disclaimer:</strong> CJC-1295 and Ipamorelin are research peptides not FDA-approved for human use.
            </p>
            <p>
              For pharmaceutical-grade peptides and medical consultation, visit{" "}
              <a
                href="https://drspeptides.com"
                target="_blank"
                rel="noopener noreferrer"
                className="text-blue-600 hover:underline"
              >
                DrsPeptides.com
              </a>
            </p>
          </div>
        </div>
      </footer>
    </div>
    </>
  );
}
